Regional News Archives - Page 86 of 190 - Journal for Clinical Studies

Current Edition

Regional News

CEOs of AbbVie, BMS, Lilly, GSK and more raise concerns about Washington’s intensifying drug-pricing push

As officials in Washington weigh contentious drug-pricing measures, there's even more evidence that pharma companies are worried about potential reform. In an open l...

16 September 2021 Regional News AbbVie | Biogen

Continue Reading →

Regional News

AstraZeneca strikes COVID-19 vaccine delivery deal with Europe, ending high-profile legal battle

At times during the pandemic, there’s been no love lost between AstraZeneca and the EU. After the U.K. pharma giant fell behind on its planned COVID-19 vaccine deliv...

8 September 2021 Regional News AstraZeneca | COVID-19

Continue Reading →

Regional News

Meet Neffy, the friendly epinephrine nasal spray from ARS Pharma awaiting FDA approval

Friendly epinephrine? Meet Neffy, ARS Pharmaceuticals’ nasal spray epinephrine to treat severe allergic reactions to food, medicines and insect bites. Neffy, now awa...

8 September 2021 Regional News Anaphylaxis | ARS Pharma

Continue Reading →

Regional News

Crippled by opioid-crisis litigation, Mallinckrodt settlement brings company closer to reorganisation

This has been a summer of reckoning for many companies that aggressively marketed opioids while downplaying their addictive power. For Mallinckrodt, which filed for ...

8 September 2021 Regional News litigation | Mallinckrodt

Continue Reading →

Regional News

After Moderna contamination mess, Takeda strikes deal with Japan to supply Novavax COVID-19 vaccines

As Moderna faces questions about contaminants found in its COVID-19 vaccines in Japan, the company’s distribution partner in the country, Takeda, is moving forward on...

8 September 2021 Regional News COVID-19 | Japan

Continue Reading →

Regional News

Bristol Myers, Pfizer score another win in their Eliquis patent defense, protecting the blockbuster until 2028

As a top-selling drug worldwide, Pfizer and Bristol Myers Squibb’s Eliquis is a major target for generic players looking to steal branded sales. But with a new court ...

8 September 2021 Regional News Bristol Myers | Eliquis

Continue Reading →

Regional News

Roche’s Polivy to hit $2.4B as doctors expect ‘significant switching’ in newly diagnosed lymphoma: analyst

Roche Pharmaceuticals CEO Bill Anderson recently pegged lymphoma drug Polivy’s potential expansion into newly diagnosed patients as a multibillion-dollar opportunity....

8 September 2021 Regional News Lymphoma | pharmaceuticals

Continue Reading →

Regional News

CDC enlists comedian to embrace the awkwardness of gynecology visits—and encourage women to go

Going to the gynaecologist can be embarrassing, weird and uncomfortable, but thanks to a new Centers for Disease Control and Prevention (CDC) web series with comedian...

1 September 2021 Regional News cancer | CDC

Continue Reading →

Regional News

AbbVie’s Imbruvica patent win sets up solid growth path after Humira’s decline: analyst

Don’t sleep on AbbVie’s recent federal court victory which upheld its patents on big-selling cancer drug Imbruvica, warns one influential biopharma analyst. In the c...

1 September 2021 Regional News AbbVie | Humira

Continue Reading →

Regional News

Sanofi refiles $3.2B Translate Bio buyout with FTC to allow more time for review

Ever since the Federal Trade Commission (FTC) unveiled its campaign to take a closer look at biopharma's M&A strategies, the industry's dealmakers have been on hi...

1 September 2021 Regional News Federal Trade Commission | FTC

Continue Reading →